Market Overview

Mid-Day Market Update: Eli Lilly Tumbles After Alzheimer's Study Fails To Meet Goals; Euroseas Shares Rise



Midway through trading Wednesday, the Dow traded up 0.20 percent to 19,061.13 while the NASDAQ declined 0.38 percent to 5,365.65. The S&P also fell, dropping 0.12 percent to 2,200.26.

Leading and Lagging Sectors

On Wednesday, industrial shares gained by 0.39 percent. Meanwhile, top gainers in the sector included Deere & Company (NYSE: DE), and Manitowoc Company Inc (NYSE: MTW).

In trading on Wednesday, utilities shares fell by 0.90 percent. Meanwhile, top losers in the sector included California Water Service Group (NYSE: CWT), down 7 percent, and MGE Energy, Inc. (NASDAQ: MGEE), down 6 percent.

Top Headline

Deere & Company (NYSE: DE) reported better-than-expected fourth-quarter results.

Deere posted Q4 earnings of $0.90 per share, versus analysts’ estimates of $0.40 per share. Its revenue came in at $5.65 billion, versus expectations of $5.38 billion.

Equities Trading UP

Euroseas Ltd. (NASDAQ: ESEA) shares shot up 58 percent to $3.04 after the company reported the purchase of drybulk vessel M/V Capetan Tassos for $4.4 million. The company also announced a deal with a company affiliated with its CEO to draw a $2 million loan to finance working capital needs.

Shares of Medigus Ltd. (NASDAQ: MDGS) got a boost, shooting up 9 percent to $1.10 after the company reported a distribution agreement with INNOVAMEDICA S.p.A. in Italy.

Deere & Company (NYSE: DE) shares were also up, gaining 10 percent to $101.48 after the company reported stronger-than-expected profit for its fourth quarter on Wednesday.

Equities Trading DOWN

Cellectar Biosciences Inc (NASDAQ: CLRB) shares dropped 31 percent to $1.49 after the company reported the pricing of its $8,000,000 public offering.

Shares of Juno Therapeutics Inc (NASDAQ: JUNO) were down 28 percent to $21.62 as the company disclosed that it has placed JCAR015 Phase II ROCKET trial on clinical hold after 2 patients suffered cerebral edema earlier this week.

Eli Lilly and Co (NYSE: LLY) was down, falling around 12 percent to $66.72 after the company’s drug solanezumab failed to meet primary endpoint for the treatment of mild dementia due to Alzheimer's disease in a late-stage study.


In commodity news, oil traded down 0.17 percent to $47.95 while gold traded down 1.94 percent to $1,190.60.

Silver traded down 1.67 percent Wednesday to $16.46, while copper rose 2.05 percent to $2.61.


European shares were mostly lower today. The eurozone’s STOXX 600 dropped 0.07 percent, the Spanish Ibex Index fell 0.28 percent, while Italy’s FTSE MIB Index rose 0.07 percent. Meanwhile the German DAX dropped 0.48 percent, and the French CAC 40 fell 0.42 percent while U.K. shares fell 0.03 percent.


The MBA’s index of mortgage application activity rose 5.50 percent for the latest week.

U.S. durable goods orders rose 4.80 percent for October, versus analysts’ expectations for a 1.50 percent growth.

Initial jobless claims rose 18,000 to 251,000 in the latest week. Economists were expecting claims to increase to 248,000 in the week.

The Markit manufacturing PMI rose to 53.90 for November, versus a prior reading of 53.40. Economists were expecting a reading of 53.40.

New-home sales declined 1.9 percent to annual rate of 563,000 in October. Economists were expecting a 593,000 pace.

The University of Michigan's consumer sentiment index increased to a final reading of 93.8 in November.

Crude supplies dropped by 1.25 million barrels for the week ended November 18, the U.S. Energy Information Administration reported. However, analysts were projecting a 250,000 drop. Gasoline supplies rose 2.32 million barrels, while distillate stockpiles gained 330,000 barrels.

The Treasury will also auction 7-year notes at 1:00 p.m. ET.

The Federal Open Market Committee will issue minutes of its latest meeting at 2:00 p.m. ET.

Posted-In: Earnings News Eurozone Commodities Global Intraday Update Markets Movers


Related Articles (CWT + CLRB)

View Comments and Join the Discussion!

Concerns Over GW Pharma's Epilepsy Drug-On-Drug Interactions Might Be Overblown

8 Notable Stocks Trading Ex-Dividend Friday, November 25